Latest media releases
UBS Global Life Sciences Conference Opens in New York
The UBS Global Life Sciences Conference opens today at the Grand Hyatt in New York City and runs through Wednesday, September 23. The annual UBS Global Life Sciences Conference is among the largest health care investor conferences in the world. Senior executives from the leading pharmaceutical, biotechnology and medical technology companies will provide their insight and outlook on the global life sciences industry. More than 2,000 people are expected to attend. Presenting companies include:
Actelion Pharmaceuticals Ltd.
Agilent Technologies, Inc.
Alexion Pharmaceuticals, Inc.
Allscripts-Misys Healthcare Solutions, Inc.
Biogen Idec Inc.
BioMed Realty Trust Inc.
Cardinal Health, Inc.
Charles River Laboratories International, Inc.
Eli Lilly and Company
F. Hoffmann - La Roche Ltd.
Gilead Sciences, Inc.
Human Genome Sciences Inc.
IMS Health, Inc.
Intuitive Surgical, Inc.
Laboratory Corporation of America Holdings
Life Technologies Corporation
Merck & Co., Inc.
Mettler-Toledo International Inc.
Myriad Genetics, Inc.
Quality Systems, Inc.
Shanghai Fosun Pharmaceutical (Group) Co., Ltd.
Smith & Nephew plc
Teva Pharmaceutical Industries Limited
Thermo Fisher Scientific Inc.
Vertex Pharmaceuticals Incorporated
Zimmer Holdings, Inc.
*This is a partial list of presenting companies. Companies subject to change.
To access the agenda, please go to www.ibb.ubs.com/Conferences.
Audio transmissions and the conference agenda will be available on the UBS Investment Bank website at www.ibb.ubs.com/Conferences. Audio transmissions of company presentations will be available live and by replay. Replays will begin three hours after the actual presentation time and will be available on the site for up to four weeks.
Headquartered in Zurich and Basel, Switzerland, UBS is one of the world's leading financial firms. It serves a discerning, international client base with its wealth management, investment banking and asset management businesses. In Switzerland, UBS is the market leader in retail and commercial banking.
UBS is present in all major financial centers worldwide. It has offices in over 50 countries, with about 38% of its employees working in the Americas, 34% in Switzerland, 15% in the rest of Europe and 13% in Asia Pacific. UBS employs more than 75,000 people around the world. Its shares are listed on the SIX Swiss Exchange, the New York Stock Exchange (NYSE) and the Tokyo Stock Exchange (TSE).